ContextVision partners with BeamWorks to advance AI-powered quantitative ultrasound imaging solutions

26 Mar 2026 13:00 CET

ContextVision, a global leader in medical imaging software, announces a
strategic research and development collaboration with BeamWorks Inc., a South
Korea-based medical AI company specializing in deep learning technologies for
real-time point-of-care diagnostics. The partnership will support
ContextVision's Data Quality initiative by combining the companies' technology
platforms to co-develop and commercialize quantitative ultrasound solutions.

The collaboration brings together ContextVision's expertise in ultrasound
image processing with BeamWorks' deep learning platform. The companies aim to
conduct joint R&D projects to develop and commercialize ultrasound-based
digital biomarkers that support point-of-care clinical decision-making.

In 2025, ContextVision initiated a quantitative ultrasound program to identify
a multiparameter biomarker for screening and staging of metabolic
dysfunction-associated steatotic liver disease (MASLD). As part of the
initiative, ContextVision set up several partnerships to augment its technical
and clinical expertise in ultrasound imaging. Also in 2025, BeamWorks launched
its first product line, the CadAI series (CadAI-B for breast and CadAI-T for
thyroid). These on-device real-time AI solutions support ultrasound
diagnostics by detecting suspicious lesions and assisting clinicians with
lesion categorization as well as malignancy scoring. Through their
collaboration, ContextVision and BeamWorks aim to leverage their respective
capabilities and portfolios to co-develop and commercialize AI-powered
quantitative ultrasound solutions, focused on MASLD, breast cancer, thyroid
nodule screening, as well as across additional clinical applications.

"We are excited to collaborate with ContextVision, a recognized global leader
in medical imaging software," said Jaeil Kim and Won Hwa Kim, Co-CEOs of
BeamWorks Inc. "This partnership combines our deep learning AI platform with
ContextVision's ultrasound imaging chain expertise, creating new opportunities
to advance quantitative ultrasound technologies and support clinicians with
improved diagnostic capabilities."

"Strategic collaborations are a key part of expanding our portfolio with
quantitative imaging solutions, offering our customer base new solutions with
significant value propositions in aiding diagnostic accuracy and treatment
monitoring" said Gerald Pötzsch, CEO of ContextVision. "BeamWorks brings
strong expertise in AI-based medical image analysis. By combining our
technologies, we aim to accelerate the development of quantitative ultrasound
imaging solutions that can deliver meaningful diagnostic insights directly at
the point-of-care."

For more information, please contact:
Gerald Pötzsch
Chief Executive Officer, ContextVision AB
gerald.potzsch@contextvision.com

About ContextVision
ContextVision is a software company specialized in image analysis and
artificial intelligence. As the global market leader within image enhancement,
we are a trusted partner to leading manufacturers of ultrasound, X-ray and MRI
equipment around the world. Our expertise is to develop powerful software
products, based on proprietary technology and artificial intelligence for
image-based applications. Our cutting-edge technology helps clinicians
accurately interpret medical images, a crucial foundation for better diagnosis
and treatment. The company, established in 1983, is based in Sweden with local
representation in the U.S., Japan, China and Korea. ContextVision is listed on
the Oslo Stock Exchange under the ticker CONTX.

About BeamWorks
BeamWorks is a company founded in 2021 by radiology experts and AI
specialists, and is headquartered in Daegu, South Korea. Leveraging its
proprietary deep learning technology, BeamWorks has developed and successfully
commercialized an on-device, real-time AI diagnostic support system that
assists ultrasound examinations critical to breast cancer and thyroid
assessment. With this commercialization, the company has established a strong
position in ultrasound-focused medical imaging AI, and is expanding its
business with global regulatory market clearances. In particular, by reducing
reliance on high-performance computing resources, BeamWorks seeks to enable
ultrasound-based diagnostic use in regions with limited access to advanced
healthcare resources, helping address gaps in accessibility to care.

More information:
Access the news on Oslo Bors NewsWeb site

669422_ContextVision partners with BeamWorks to advance AI-powered quantitative ultrasound imaging solutions.pdf